Amplia Therapeutics Limited

ASX:ATX.AX

0.235 (AUD) • At close July 3, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) AUD.

2025 Q22024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q2
Operating Activities:
Net Income -2.814-3.374-1.129-3.331-2.912-2.322-1.323-1.77-0.511-1.334-0.885-1.152-0.718-1.802-2.495-3.594-3.482-2.808-2.135-2.618-2.618-2.248-2.248-1.694-1.694
Depreciation & Amortization 0.0430.0430.0430.0440.0290.0020.00200000.0010.0010.0050.0150.0190.0170.0520.5170.7740.7740.7370.7370.6650.665
Deferred Income Tax 000-0.89700.79300.8350-0.030-0.5510-1.20-0.24501.06600.1690.1690-0.618-0.119-0.119
Stock Based Compensation 0.0670.040.0460.1280.0810.030.0310.1820.1720.0880.1150.1470.0970.0030.0710.1730.7560.0810.1470.0890.08900.6230.1070.107
Change In Working Capital 0-2.04500.680-0.8250-1.0180-0.05900.40401.19700.0710-1.1470-0.258-0.2580-0.0050.0120.012
Accounts Receivables 0-2.04500.680-0.8250-1.0180-0.05900.40401.19700.0710-1.1470-0.258-0.2580-0.0050.0120.012
Change In Inventory 0000000000000000000000000
Change In Accounts Payables 0000000000000000000000000
Other Working Capital 0000000000000000000000000
Other Non Cash Items 1.5323.751-2.3711.0220.0050.167-0.922-0.207-0.4280.361-0.2290.1410.092-1.5451.003-0.8530.730.3350.2440.0250.0250.7080.7080.1520.152
Operating Cash Flow -1.172-1.584-3.543-2.353-2.936-2.156-2.246-1.977-0.939-0.974-1.114-0.46-0.528-2.143-1.406-4.182-1.98-3.488-1.227-1.989-1.989-0.802-0.802-0.877-0.877
Investing Activities:
Investments In Property Plant And Equipment -0-0.0020-0.004-0.014-0.008-0.007-0.0050000-0.0030-0.004-0.009-0.037-0.025-0.014-0.013-0.013-0-0.00100
Acquisitions Net 0000000000000000000000000
Purchases Of Investments 0000000000000000000000000
Sales Maturities Of Investments 0000000000000000000000000
Other Investing Activites 0000-0.041-0.01200000000.00600000-0-0-0.8020.8020.0030.003
Investing Cash Flow -0-0.0029.257-0.004-0.055-0.02-0.007-0.0051.108-1.1081.2410-0.0030.006-0.004-0.009-0.037-0.025-0.014-0.013-0.013-0.8020.8010.0030.003
Financing Activities:
Debt Repayment -1.5080-0.040-0.026000000000000000000.53300
Common Stock Issued 000-00.02111.5133.5760.0673.5960.8731.08500000000005.0225.02200
Common Stock Repurchased 000000000000000000000-0.573-0.57300
Dividends Paid 0000000000000000000000-2.25500
Other Financing Activities 3.873-0.688-0.046-0.070.01213.6133.5760.0673.5960.8731.0850-0.0120-0.0132.1996.5164.0084.08900-0.8020.8020.3570.357
Financing Cash Flow 2.365-0.687-0.086-0.07-0.01413.6133.5760.0673.5960.8731.0850-0.0120-0.0132.1996.5164.0084.089-0.001-0.001-0.80210.2340.3570.357
Other Information:
Effect Of Forex Changes On Cash -0.0190.0030.0280.0040.076-0-0-0.001-0.0010.001-0.0040.0070.0080.031-0.005-0.0210.077-0.066-0.0770.0760.0766.319-6.322-0.006-0.006
Net Change In Cash 4.558-2.271-3.6-2.423-2.92911.4381.323-1.9162.657-0.0991.207-0.453-0.535-2.106-1.428-2.0144.5770.4292.771-5.5165.5161.956-0.088-1.045-1.045
Cash At End Of Period 4.5583.3855.6579.25711.6814.6093.1711.8483.7651.1081.2071.2411.6942.2294.3355.7637.7773.2012.77105.5161.9850.0290.1170.117